IMR Press / CEOG / Volume 26 / Issue 3-4 / pii/1999037

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Effectiveness of “core biopsy” by the mammotome device for diagnosis of inflammatory carcinoma

Show Less
1 Institute of Radiology, University of Sassari (Italy)
2 Department of Pharmacology, Gynaecology and Obstetrics, University of Sassari (Italy)
3 Institute of Pathology, University of Sassari (Italy)
Clin. Exp. Obstet. Gynecol. 1999, 26(3-4), 181–182;
Published: 10 September 1999
Abstract

Objective: To assess the usefulness of “Mammotome” device for the diagnosis of the inflammatory breast carcinoma. Material and methods: We studied 6 patients, aged 43-79 years, with clinical evidence of inflammatory breast carcinoma. We compared two sampling techniques, a cytologic one by Fine Needle Aspiration (FNA) and a microhistologic one by “Mammotome”. Results: Cytologic sampling by FNA permitted certain diagnosis of malignant lesions in 2 out of 6 cases, while the “Mammo­tome” device confirmed the correct diagnosis in all 6 considered cases. Conclusions: The “Mammotome” device proved more useful in the diagnosis of inflammatory breast carcinoma than FNA and it can be a valide alternative to surgical biopsy.

Keywords
Inflammatory breast carcinoma
Fine Needle Aspiration
“Mammotome” device
Share
Back to top